Trials / Sponsors / Pamela L. Kunz
Pamela L. Kunz
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Neuroendocrine Tumors, Carcinoid Tumors, Adrenal Gland Tumors | Phase 2 | 2009-03-01 |
| Completed | Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors Neuroendocrine Tumors | Phase 2 | 2006-11-01 |